KRAS and pancreatic neoplasm: In a recent study, we also found that the inhibition of GRP78 by YUM70 could suppress oncogenic KRAS protein expression and reduce the viability of lung, colon, and pancreatic cancer cells bearing various KRAS mutations [26].